Middle East And Africa Ophthalmic Drugs Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	109 Pages	Triton Market Research	April, 2024	TRTN18748651

Best Price Guarantee
Price	from $1,500
Length	109 Pages
Publisher	Triton Market Research
Published Date	April, 2024
SKU	TRTN18748651

Middle East And Africa Ophthalmic Drugs Market 2023-2030

Market Outlook

Triton’s research report examines that the Middle East and Africa ophthalmic drugs market is expected to rise at 7.17% CAGR in revenue for the forecasted years 2023-2030. The United Arab Emirates (UAE), Saudi Arabia, Turkey, and the Rest of the Middle East & Africa are the countries studied in this report.

Amidst healthcare challenges in South Africa, eye health requires prominent attention due to the rise in conditions like diabetic retinopathy and age-related macular degeneration. The government and health authorities take initiatives to cure and prevent eye diseases. In this regard, the South African Health Products Regulatory Authority (SAHPRA) has major control over the market by regulating the access and quality of ophthalmic drug products. Thus, the demand for these drugs is rising owing to the existing opportunities of providing accessible eye care and specialized treatment to everyone.

Similarly, Saudi Arabia has made recent developments with two companies, Novartis and Roche, to innovate in the ophthalmic drug delivery system. Collaborations with the local healthcare providers also have a positive influence on the studied market. The Saudi Food and Drug Authority (SFDA) is also responsible for setting standards for market entrants to provide high quality and safe ophthalmic drug products.

Competitive Outlook

The key companies listed in the ophthalmic drugs market are Accutome Inc, Genentech Inc, Thea Pharma Inc, AbbVie Inc, Johnson & Johnson, and Novartis AG.

1. Middle East And Africa Ophthalmic Drugs Market - Summary
2. Industry Outlook: 2.1. Technology Snapshot; 2.2. Impact Analysis On The Ophthalmic Drugs Market; 2.2.1. Covid-19 Impact On The Ophthalmic Drugs Market; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Market Maturity Analysis; 2.5. Regulatory Framework; 2.6. Key Buying Impact Analysis; 2.7. Key Market Strategies; 2.7.1. Collaborations; 2.7.2. Product Launches; 2.7.3. Mergers & Acquisitions; 2.8. Market Drivers; 2.8.1. Aging Population Vulnerable To Eye Disorders; 2.8.2. Progress In Drug Delivery Technologies; 2.8.3. Escalating Incidence Of Ocular Diseases; 2.8.4. Reimbursement Policies By Healthcare Systems; 2.9. Market Challenges; 2.9.1. Challenging Timelines For Product Approval; 2.9.2. Adverse Effects Associated With Ophthalmic Drug Usage; 2.10. Market Opportunities; 2.10.1. Surge In Interest Regarding Topically Administered Ophthalmic Drugs; 2.10.2. Increase In Approvals For Innovative Ophthalmic Therapies; 2.11. Analyst Perspective
3. Middle East And Africa Ophthalmic Drugs Market – By Type: 3.1. Prescription Drugs; 3.2. Over-the-counter Drugs
4. Middle East And Africa Ophthalmic Drugs Market – By Condition: 4.1. Dry Eye; 4.2. Glaucoma; 4.3. Infection/Inflammation/Allergies; 4.4. Retinal Disorder; 4.4.1. Wet-age Related Macular Degeneration; 4.4.2. Dry-age Related Macular Degeneration; 4.4.3. Diabetic Retinopathy; 4.4.4. Other Retinal Disorders; 4.5. Other Conditions
5. Middle East And Africa Ophthalmic Drugs Market – By Therapeutic Type: 5.1. Anti-glaucoma; 5.2. Anti-infection; 5.3. Anti-inflammatory; 5.4. Anti-allergy; 5.5. Other Therapeutic Types
6. Middle East And Africa Ophthalmic Drugs Market – By Delivery Method: 6.1. Gels; 6.2. Eye Solutions & Suspensions; 6.3. Capsules & Tablets; 6.4. Eye Drops; 6.5. Ointments
7. Middle East And Africa Ophthalmic Drugs Market – By Channel: 7.1. Hospital Pharmacies; 7.2. Drug Stores; 7.3. Online Pharmacies; 7.4. Other Channels
8. Middle East And Africa Ophthalmic Drugs Market – Country Outlook: 8.1. United Arab Emirates; 8.1.1. United Arab Emirates Ophthalmic Drugs Market Forecast & Prospects; 8.2. Turkey; 8.2.1. Turkey Ophthalmic Drugs Market Forecast & Prospects; 8.3. Saudi Arabia; 8.3.1. Saudi Arabia Ophthalmic Drugs Market Forecast & Prospects; 8.4. South Africa; 8.4.1. South Africa Ophthalmic Drugs Market Forecast & Prospects; 8.5. Rest Of Middle East & Africa; 8.5.1. Rest Of Middle East & Africa Ophthalmic Drugs Market Forecast & Prospects
9. Competitive Landscape: 9.1. Abbvie Inc; 9.1.1. Overview; 9.1.2. Product Portfolio; 9.1.3. Key Strengths; 9.1.4. Key Challenges; 9.2. Bausch Health Companies Inc; 9.2.1. Overview; 9.2.2. Product Portfolio; 9.2.3. Key Strengths; 9.2.4. Key Challenges; 9.3. Johnson & Johnson; 9.3.1. Overview; 9.3.2. Product Portfolio; 9.3.3. Key Strengths; 9.3.4. Key Challenges; 9.4. Novartis Ag; 9.4.1. Overview; 9.4.2. Product Portfolio; 9.4.3. Key Strengths; 9.4.4. Key Challenges; 9.5. Regeneron Pharmaceuticals Inc; 9.5.1. Overview; 9.5.2. Product Portfolio; 9.5.3. Key Strengths; 9.5.4. Key Challenges; 9.6. Sun Pharmaceutical Industries Ltd; 9.6.1. Overview; 9.6.2. Product Portfolio; 9.6.3. Key Strengths; 9.6.4. Key Challenges; 9.7. Accutome Inc; 9.7.1. Overview; 9.7.2. Product Portfolio; 9.7.3. Key Strengths; 9.7.4. Key Challenges; 9.8. Genentech Inc; 9.8.1. Overview; 9.8.2. Product Portfolio; 9.8.3. Key Strengths; 9.8.4. Key Challenges; 9.9. Thea Pharma Inc; 9.9.1. Overview; 9.9.2. Product Portfolio; 9.9.3. Key Strengths; 9.9.4. Key Challenges; 9.10. Pfizer Inc; 9.10.1. Overview; 9.10.2. Product Portfolio; 9.10.3. Key Strengths; 9.10.4. Key Challenges
10. Research Methodology & Scope: 10.1. Research Scope & Deliverables; 10.2. Sources Of Data; 10.3. Research Methodology
Tables List: Table 1: Middle East And Africa Ophthalmic Drugs Market, By Country, 2023-2030 (In $ Million); Table 2: Regulatory Framework; Table 3: List Of Collaborations; Table 4: List Of Product Launches; Table 5: List Of Mergers & Acquisitions; Table 6: Middle East And Africa Ophthalmic Drugs Market, By Country Outlook, 2023-2030 (In $ Million); Table 7: Middle East And Africa Ophthalmic Drugs Market, By Type, 2023-2030 (In $ Million); Table 8: Middle East And Africa Ophthalmic Drugs Market, By Condition, 2023-2030 (In $ Million); Table 9: Middle East And Africa Ophthalmic Drugs Market, By Retinal Disorder, 2023-2030 (In $ Million); Table 10: Middle East And Africa Ophthalmic Drugs Market, By Therapeutic Type, 2023-2030 (In $ Million); Table 11: Middle East And Africa Ophthalmic Drugs Market, By Delivery Method, 2023-2030 (In $ Million); Table 12: Middle East And Africa Ophthalmic Drugs Market, By Channel, 2023-2030 (In $ Million)
Figures List: Figure 1: Technology Snapshot; Figure 2: Market Maturity Analysis; Figure 3: Middle East And Africa Ophthalmic Drugs Market, By Type, 2022 & 2030 (In %); Figure 4: Middle East And Africa Ophthalmic Drugs Market, By Prescription Drugs, 2023-2030 (In $ Million); Figure 5: Middle East And Africa Ophthalmic Drugs Market, By Over-the-counter Drugs, 2023-2030 (In $ Million); Figure 6: Middle East And Africa Ophthalmic Drugs Market, By Condition, 2022 & 2030 (In %); Figure 7: Middle East And Africa Ophthalmic Drugs Market, By Dry Eye, 2023-2030 (In $ Million); Figure 8: Middle East And Africa Ophthalmic Drugs Market, By Glaucoma, 2023-2030 (In $ Million); Figure 9: Middle East And Africa Ophthalmic Drugs Market, By Infection/Inflammation/Allergies, 2023-2030 (In $ Million); Figure 10: Middle East And Africa Ophthalmic Drugs Market, By Retinal Disorder, 2023-2030 (In $ Million); Figure 11: Middle East And Africa Ophthalmic Drugs Market, By Retinal Disorder, 2022 & 2030 (In %); Figure 12: Middle East And Africa Ophthalmic Drugs Market, By Wet Age-related Macular Degeneration, 2023-2030 (In $ Million); Figure 13: Middle East And Africa Ophthalmic Drugs Market, By Dry Age-related Macular Degeneration, 2023-2030 (In $ Million); Figure 14: Middle East And Africa Ophthalmic Drugs Market, By Diabetic Retinopathy, 2023-2030 (In $ Million); Figure 15: Middle East And Africa Ophthalmic Drugs Market, By Other Retinal Disorders, 2023-2030 (In $ Million); Figure 16: Middle East And Africa Ophthalmic Drugs Market, By Other Conditions, 2023-2030 (In $ Million); Figure 17: Middle East And Africa Ophthalmic Drugs Market, By Therapeutic Type, 2022 & 2030 (In %); Figure 18: Middle East And Africa Ophthalmic Drugs Market, By Anti-glaucoma, 2023-2030 (In $ Million); Figure 19: Middle East And Africa Ophthalmic Drugs Market, By Anti-infection, 2023-2030 (In $ Million); Figure 20: Middle East And Africa Ophthalmic Drugs Market, By Anti-inflammatory, 2023-2030 (In $ Million); Figure 21: Middle East And Africa Ophthalmic Drugs Market, By Anti-allergy, 2023-2030 (In $ Million); Figure 22: Middle East And Africa Ophthalmic Drugs Market, By Other Therapeutic Types, 2023-2030 (In $ Million); Figure 23: Middle East And Africa Ophthalmic Drugs Market, By Delivery Method, 2022 & 2030 (In %); Figure 24: Middle East And Africa Ophthalmic Drugs Market, By Gels, 2023-2030 (In $ Million); Figure 25: Middle East And Africa Ophthalmic Drugs Market, By Eye Solutions & Suspensions, 2023-2030 (In $ Million); Figure 26: Middle East And Africa Ophthalmic Drugs Market, By Capsules & Tablets, 2023-2030 (In $ Million); Figure 27: Middle East And Africa Ophthalmic Drugs Market, By Eye Drops, 2023-2030 (In $ Million); Figure 28: Middle East And Africa Ophthalmic Drugs Market, By Ointments, 2023-2030 (In $ Million); Figure 29: Middle East And Africa Ophthalmic Drugs Market, By Channel, 2022 & 2030 (In %); Figure 30: Middle East And Africa Ophthalmic Drugs Market, By Hospital Pharmacies, 2023-2030 (In $ Million); Figure 31: Middle East And Africa Ophthalmic Drugs Market, By Drug Stores, 2023-2030 (In $ Million); Figure 32: Middle East And Africa Ophthalmic Drugs Market, By Online Pharmacies, 2023-2030 (In $ Million); Figure 33: Middle East And Africa Ophthalmic Drugs Market, By Other Channels, 2023-2030 (In $ Million); Figure 34: Middle East And Africa Ophthalmic Drugs Market, By Country Outlook, 2022 & 2030 (In %); Figure 35: United Arab Emirates Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 36: Turkey Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 37: Saudi Arabia Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 38: South Africa Ophthalmic Drugs Market, 2023-2030 (In $ Million); Figure 39: Rest Of Middle East & Africa Ophthalmic Drugs Market, 2023-2030 (In $ Million)